$176.01 0.12 (0.07%)
17:48 EDT AMGN Stock Quote Delayed 15 Minutes
Previous Close $176.01
Market Cap 116.47B
PE Ratio 55.88
Volume (Avg. Vol.) 2.08M
Day's Range 175.52 - 176.77
52-Week Range 166.30 - 210.19
Dividend & Yield 5.28 (3.00%)
AMGN Stock Predictions, Articles, and Amgen News
- From InvestorPlace
- From the Web
Investors who are feeling a little gutsy should consider these five stocks to buy to take advantage of the market's weariness right now.
If you’re looking for the next big thing in investing, these three down but not out biotech stocks are the way to go.
These beaten-down healthcare stocks still have plenty of long-term potential. Here's what investors need to know about each.
CVS, Twilio, Amgen and Estee Lauder all reported earnings. Alibaba stock is breaking out. Here are our top stock trades to watch now.
Amgen reported its latest quarterly earnings results after hours today, bringing in a profit that topped expectations, yet AMGN stock fell.
The stock charts of AMGN, CTXS and GS stock are ready to start the last trading day of the week on a trade-worthy foot.
Given the markets’ many question marks, these safe dividend stocks to buy offer reliable yields and steady growth potential.
These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.
Amgen earnings (AMGN) were better than what analysts were calling for after hours, but AMGN stock slid as the its guidance missed the mark.
Despite their indispensable demand, pharmaceutical stocks face tough roadblocks as competition for breakthrough drugs intensifies.
The stock charts of AMGN, DAL and MDLZ are put under the spotlight on this week's hump-day. Here's what to watch.
Verizon, CBS and Amgen are just some of the stocks to buy to get the most out of the usual November and December rally.
If you want some set-it-and-forget-it holdings for your portfolio, these S&P 500 stocks are ideal stocks to buy.
AMGN stock is still riding on a rocky road despite news of a new FDA approval. Here's what Amgen investors need to know.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!